Low InTensity Exercise Intervention in PAD

NACompletedINTERVENTIONAL
Enrollment

305

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

October 19, 2020

Study Completion Date

October 19, 2020

Conditions
Peripheral Artery Disease
Interventions
BEHAVIORAL

Exercise

Participants in one of the exercise intervention groups will attend once weekly sessions at the medical center for the first four weeks of the study (Weeks 1-4, Phase I). During weeks 5-52 (Phase II), they will receive weekly telephone calls from a study coach.

OTHER

Attention control

Our attention control group controls for the possibility that regular contact with the study team may improve outcomes in participants randomized to the intervention. Participants randomized to the control group will attend weekly one-hour educational sessions at Northwestern University for the first four weeks of the intervention (Phase I). These sessions are on topics of interest to the typical PAD patient and are led by physicians and other health care workers. Topics include Medicare Part D, nutritional supplements, and cancer screening. During Phase II (weeks 5-52), the attention control group will receive weekly telephone calls, lasting 5-15 minutes, with information on a health-related topic.

Trial Locations (4)

15213

University of Pittsburgh Medical Center, Pittsburgh

55455

University of Minnesota, Minneapolis

60611

Northwestern University, Chicago

70121

Ochsner Baptist, Tulane University, New Orleans

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Northwestern University

OTHER

NCT02538900 - Low InTensity Exercise Intervention in PAD | Biotech Hunter | Biotech Hunter